Article info
PDFLetter
How dangerous are norovirus infections in patients with rheumatic diseases treated with biologics and DMARDs? Follow-up on a local outbreak and comparison with a control cohort
- Correspondence to Professor Christoph Fiehn, ACURA Center for Rheumatic Diseases, Rotenbachtalstr. 5, Baden-Baden 76530, Germany; c.fiehn{at}acura-kliniken.com
Citation
How dangerous are norovirus infections in patients with rheumatic diseases treated with biologics and DMARDs? Follow-up on a local outbreak and comparison with a control cohort
Publication history
- Received August 12, 2013
- Revised September 27, 2013
- Accepted November 5, 2013
- First published November 25, 2013.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions